Sodium Tartrate

FAQ Print

Sodium Tartrate

by Wikikenko.com

|

Last updated on


  • Chemical Name: Disodium (2R,3R)-2,3-dihydroxybutanedioate
  • Generic Name: Sodium tartrate
  • Chemical Class: Beta hydroxy acids and derivatives
  • Formulations: Powder, crystalline solid
  • Brand Names: (Primarily sold as a chemical/food additive; not marketed under specific pharmaceutical brands)
  • Manufacturer: Ataman Kimya, IndiaMART suppliers (India), Alfa Aesar, Sigma-Aldrich, Merck
  • Regulatory Status: Approved (GRAS as food additive E335; permitted as pharmaceutical excipient)
  • Origin: Byproduct of wine manufacturing; discovered in Europe, 18th–19th century

Sodium tartrate, a white crystalline compound with significant applications in both the food industry and pharmaceutical sector, serves multiple functions ranging from an emulsifier to a therapeutic agent. This comprehensive review explores its chemical properties, medical applications, mechanism of action, and safety profile, providing healthcare professionals with essential information about this versatile substance.

Introduction

Sodium tartrate (C₄H₄Na₂O₆) is a disodium salt of L-(+)-tartaric acid characterized by transparent, colorless, and odorless crystals. Historically obtained as a byproduct of wine manufacturing, this compound has found its way into numerous applications across food science and medicine. It is generally recognized as safe (GRAS) by regulatory authorities as a direct human food ingredient, primarily functioning as an emulsifier and pH control agent.

Beyond its food applications, sodium tartrate plays a role in pharmaceutical formulations, where it serves as a salt-forming agent and excipient in various medicinal preparations. This review aims to provide a comprehensive understanding of sodium tartrate’s properties, applications, and safety considerations in medical contexts.

Chemical Structure

Sodium tartrate, chemically known as disodium 2,3-dihydroxybutanedioate, possesses the molecular formula C₄H₄Na₂O₆. It contains two sodium cations paired with the tartrate anion, which features two hydroxyl groups and two carboxylate groups arranged around a four-carbon backbone.

The molecule’s structure grants it excellent water solubility and makes it an effective sequestering agent due to the arrangement of its hydroxyl and carboxylate groups, which can form complexes with various metal ions. The stereochemistry of the tartrate component is significant, as sodium tartrate typically contains the L(+)-tartaric acid form, which has different biological properties compared to its D(-) isomer.

Tartrate-Based Medicines

While sodium tartrate itself is primarily used as an excipient rather than an active pharmaceutical ingredient, the tartrate ion serves as an important counter-ion in numerous medications. Below are eight significant medications that utilize tartrate salts in their formulations:

  1. Metoprolol tartrate – A selective beta-1 blocker used for hypertension, angina, and to reduce mortality after myocardial infarction
  2. Epinephrine bitartrate – Used for hypersensitivity reactions, bronchospasm, and cardiac arrest
  3. Isoproterenol bitartrate – A beta-adrenergic agonist used in cardiac conditions and bronchospasm
  4. Arformoterol tartrate – A long-acting beta2-adrenergic agonist for maintenance treatment of COPD
  5. Terbutaline – Available as a tartrate salt, used as a bronchodilator and tocolytic agent
  6. Ephedrine – An alpha and beta-adrenergic agonist indicated for hypotension and respiratory conditions
  7. Fenoterol – A beta-2 adrenergic agonist used for asthma treatment
  8. Atropine – Available in various salt forms including sulfate, for anticholinergic effects

Mechanism of Action

Sodium tartrate functions through multiple mechanisms depending on its application. As an emulsifier in food and pharmaceutical preparations, it reduces surface tension between immiscible phases, creating stable suspensions and emulsions. When used as a pH control agent, it helps maintain optimal acid-base conditions in various formulations.

In its medicinal applications as an osmotically acting laxative, sodium tartrate draws water into the intestinal lumen through osmotic effects, increasing the water content of stools and promoting bowel movements. This mechanism is similar to other saline laxatives but with a generally milder action profile. Additionally, in laboratory settings, sodium tartrate is utilized in the Karl Fischer titration method for determining water content in various substances, where it serves as a buffering agent.

Pharmacokinetics

The pharmacokinetic profile of sodium tartrate and related tartrates exhibits significant species variation. Studies have shown that the metabolism of L(+)-tartaric acid and its potassium sodium salt demonstrates greater absorption in rats compared to humans. When ingested orally, sodium tartrate is partially absorbed in the gastrointestinal tract, with a considerable portion remaining in the intestinal lumen to exert osmotic effects.

The absorbed portion undergoes metabolism primarily through the tricarboxylic acid cycle, with approximately 20-30% of the administered dose being eliminated unchanged in urine. The relatively limited systemic absorption explains the localized action of sodium tartrate when used as a laxative agent. The elimination half-life is relatively short, contributing to its safety profile when used at recommended doses.

Therapeutic Uses

Therapeutic CategorySpecific UsesDosage FormsNotes
LaxativeOsmotically acting laxative for constipationOral solutions, powdersATC code A06AD21
Pharmaceutical ExcipientEmulsifier in various formulationsIngredient in tablets, suspensionsEnhances stability and dissolution
pH Control AgentBuffer in pharmaceutical preparationsComponent in solutionsMaintains optimal pH for drug stability
SequestrantBinding agent in pharmaceutical formulationsIngredient in various dosage formsPrevents degradation by metal ions
Laboratory ReagentKarl Fischer titration for water determinationAnalytical grade powderUsed in pharmaceutical quality control

Side Effects

Sodium tartrate is generally well-tolerated when used at recommended doses. However, excessive consumption can lead to adverse effects. Daily doses of 10 g sodium tartrate have been reported to cause nausea, vomiting, and abdominal cramps in a minority of patients (< 2.1%) with pre-existing health problems. These gastrointestinal disturbances are typically mild and self-limiting.

More serious adverse effects have been documented with high doses of tartrates, including four cases of acute tubular necrosis in patients who had consumed large amounts of tartaric acid, although the specific form of tartaric acid was not specified in these reports. It’s worth noting that the European Food Safety Authority (EFSA) has determined that renal effects reported with tartrates were most likely attributable to the presence of the D(−)-form of tartaric acid rather than the L(+)-form typically found in sodium tartrate.

Drug Interactions

While specific drug interactions with sodium tartrate are not extensively documented, general considerations apply. As an excipient or salt-forming agent, sodium tartrate may potentially alter the absorption or bioavailability of certain active pharmaceutical ingredients. When used as a laxative, it may theoretically accelerate gastrointestinal transit time, potentially reducing the absorption of concurrently administered medications.

Caution is advised when using sodium tartrate-containing products with drugs having narrow therapeutic windows or those requiring precise timing for absorption. Additionally, the sodium content in sodium tartrate may be clinically significant for patients on sodium-restricted diets, particularly those with hypertension, heart failure, or renal impairment.

Safety Considerations

The European Food Safety Authority has established a group Acceptable Daily Intake (ADI) for L(+)-tartaric acid-tartrates (E 334-337 and E 354) of 240 mg/kg body weight per day, expressed as tartaric acid. This indicates a relatively favorable safety profile when used within recommended limits.

Special considerations should be given to certain patient populations. Individuals with renal impairment may have decreased clearance of tartrates, potentially increasing the risk of adverse effects. Similarly, patients with electrolyte disturbances should use sodium tartrate with caution due to its potential effects on fluid and electrolyte balance.

Pregnant and lactating women should consult healthcare professionals before using products containing sodium tartrate, although no specific contraindications have been established. While generally recognized as safe, sodium tartrate should be used at the lowest effective dose for the shortest duration necessary, particularly when used for therapeutic purposes.

Regulatory Status

Sodium tartrate enjoys broad regulatory acceptance globally. In the United States, it is classified by the Food and Drug Administration (FDA) as Generally Recognized as Safe (GRAS) as a direct human food ingredient. It is listed in the FDA’s database of food substances with the technical effects of “emulsifier or emulsifier salt, pH control agent, sequestrant”.

In Europe, sodium tartrate is known as E335(II) in the European food additive numbering system and is approved for use in various food applications. The European Medicines Agency (EMA) recognizes sodium tartrate as an acceptable excipient in pharmaceutical formulations.

The World Health Organization’s Anatomical Therapeutic Chemical (ATC) classification system categorizes sodium tartrate under code A06AD21, classified as an “osmotically acting laxative” within the broader category of “drugs for constipation” under “alimentary tract and metabolism”. This classification reflects its recognized therapeutic role in medical practice.

Conclusion

Sodium tartrate represents a versatile compound with applications spanning food technology and pharmaceutical science. Its favorable safety profile and functional versatility make it valuable in various medical contexts, from an excipient in drug formulations to a therapeutic agent for constipation. When used appropriately, sodium tartrate offers significant benefits with minimal risk of adverse effects.

Healthcare professionals should maintain awareness of sodium tartrate’s properties, potential applications, and limitations to optimize its use in clinical practice. Further research into its interactions with specific medications and its effects in special patient populations would enhance our understanding of this commonly used compound and potentially expand its applications in medicine.


0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted


You might also like